Bioeclipse Therapeutics, Inc

BioEclipse Therapeutics™ is a clinical-stage oncology company developing a new generation of precise, targeted, immunotherapies that bring hope to patients with advanced cancer who have few treatment options due to the challenges of resistant and recurrent cancers. Solid tumors have been a challenging obstacle for all cancer therapies, including immunotherapies, reporting high failuure rates. For six decades researchers have taken steps towards a cure, with remarkable progress in liquid tumors, but few inroads into solid tumors representing 90% of all cancers. Our technology represents a transformative approach that captures the true power of both innate and adaptive immunity to effectively treat even refractory solid tumors.